Logo

Bio-Rad Receives the US FDA's Emergency Use Authorization for its Droplet Digital PCR Test Kit to Detect COVID-19

Share this

Bio-Rad Receives the US FDA's Emergency Use Authorization for its Droplet Digital PCR Test Kit to Detect COVID-19

Shots:

  • The US FDA has granted EUA for its COVID-19 Droplet Digital PCR (ddPCR) test that runs on Bio-Rad's QX200 and QXDx ddPCR systems
  • Due to its high sensitivity- the test is well-suited for screening upper respiratory samples in patients with a low viral load as compared to other quantitative PCR tests. The test provides clinicians with a high degree of sensitivity to improve the accuracy of reported results
  • The EUA marks the Bio-Rad’s second EUA that has been granted for COVID-19. On Apr 30- 2020- the company has received EUA for its serology test to detect AB to the COVID-19

Click here ­to­ read full press release/ article | Ref: Bio-Rad | Image: Bio-Rad


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions